High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting
Huanan Li
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorShaoquan Bian
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorYihang Huang
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorCorresponding Author
Jie Liang
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Correspondence to: J. Liang; e-mail: [email protected] or Y. Fan; [email protected]Search for more papers by this authorCorresponding Author
Yujiang Fan
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Correspondence to: J. Liang; e-mail: [email protected] or Y. Fan; [email protected]Search for more papers by this authorXingdong Zhang
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorHuanan Li
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorShaoquan Bian
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorYihang Huang
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorCorresponding Author
Jie Liang
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Correspondence to: J. Liang; e-mail: [email protected] or Y. Fan; [email protected]Search for more papers by this authorCorresponding Author
Yujiang Fan
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Correspondence to: J. Liang; e-mail: [email protected] or Y. Fan; [email protected]Search for more papers by this authorXingdong Zhang
National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu 610064, China
Search for more papers by this authorAbstract
pH-sensitive pullulan-doxorubicin (DOX) conjugates were synthesized by attaching DOX onto pullulan derivate through hydrazone bond that was stable under neutral environment but readily cleaved under mildly acidic condition. By changing the feed ratio of DOX to the pullulan derivate, conjugates with drug-loading content up to 30 wt % were obtained. In aqueous solution, the conjugates spontaneously formed uniform core-shell structured nanoparticles with DOX as core and pullulan as shell. The diameters of the nanoparticles ranged from 50 to 110 nm according to the drug-loading content. In vitro releasing experiments showed that more than 75% DOX released within 2 h at pH 5.0, while less than 15% DOX released after 12 h at pH 7.4. This pH-responsive manner of DOX release might assist the quick diffusion of DOX from the acidic endosome/lysosome and the intracellular transfer into the nucleus. Pullulan on the nanoparticles surface provided the nanoparticles with active targeting property to hepatic cells through specific interaction with asialoglycoprotein receptors on the membrane of hepatic cells, without the necessity of introducing any extra ligand. These pullulan-DOX conjugate nanoparticles were expected to be promising drug delivery system for liver targeting antitumor chemotherapy. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 150–159, 2014.
REFERENCES
- 1Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK.Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size.Cancer Res1995; 55: 3752–3756.
- 2Matsumura Y, Maeda H.A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.Cancer Res1986; 46( Part 1): 6387–6392.
- 3MacEwan SR, Callahan DJ, Chilkoti A.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Nanomedicine (Lond)2010; 5: 793–806.
- 4Maeda H, Bharate GY, Daruwalla J.Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.Eur J Pharmaceutics Biopharmaceutics2009; 71: 409–419.
- 5Simon SM, Schindler M.Cell biological mechanisms of multidrug resistance in tumors.Proc Natl Acad Sci USA1994; 91: 3497–3504.
- 6Warren L, Jardillier JC, Ordentlich P.Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.Cancer Res1991; 51: 1996–2001.
- 7Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BA, Peters GJ, Jansen G.Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells.J Biol Chem2003; 278: 6680–6686.
- 8Panyam J, Labhasetwar V.Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells.Pharmaceutical Res2003; 20: 212–220.
- 9Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, Kim SY, Cho YW.N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: Endocytosis, exocytosis and drug release.J Control Release2006; 115: 37–45.
- 10Nomura Y, Ikeda M, Yamaguchi N, Aoyama Y, Akiyoshi K.Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone.FEBS Lett2003; 553: 271–276.
- 11Saito G, Swanson JA, Lee KD.Drug delivery strategy utilizing conjugation via reversible disulfide linkages: Role and site of cellular reducing activities.Adv Drug Deliv Rev2003; 55: 199–215.
- 12Kaneo Y, Tanaka T, Nakano T, Yamaguchi Y.Evidence for receptor-mediated hepatic uptake of pullulan in rats.J Control Release2001; 70: 365–373.
- 13Burgalassi S, Chetoni P, Panichi L, Boldrini E, Saettone MF.Xyloglucan as a novel vehicle for timolol: Pharmacokinetics and pressure lowering activity in rabbits.J Ocular Pharmacol Therapeutics2000; 16: 497–509.
- 14Cheng KC, Demirci A, Catchmark JM.Pullulan: Biosynthesis, production, and applications.Appl Microbiol Biotechnol2011; 92: 29–44.
- 15Shingel K, Petrov P.Behavior of γ-ray-irradiated pullulan in aqueous solutions of cationic (cetyltrimethylammonium hydroxide) and anionic (sodium dodecyl sulfate) surfactants.Colloid Polym Sci2002: 176–182.
- 16Yamaoka T, Tabata Y, Ikada Y.Body distribution profile of polysaccharidesafter intravenous administration.Drug Deliv1993; 1: 75–82.
- 17Rekha M, Sharma C.Pullulan as a promising biomaterial for biomedical applications: A perspective.Trends Biomater Artif Organ2007; 20: 116–121.
- 18Trere D, Fiume L, De Giorgi LB, Di Stefano G, Migaldi M, Derenzini M.The asialoglycoprotein receptor in human hepatocellular carcinomas: Its expression on proliferating cells.Br J Cancer1999; 81: 404–408.
- 19Cao Y, Gu Y, Ma H, Bai J, Liu L, Zhao P, He H.Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin.Int J Biol Macromol2010; 46: 245–249.
- 20Lee ES, Na K, Bae YH.Super pH-sensitive multifunctional polymeric micelle.Nano Lett2005; 5: 325–329.
- 21Shen Y, Tang H, Zhan Y, Van Kirk EA, Murdoch WJ.Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery.Nanomedicine2009; 5: 192–201.
- 22Lu D, Wen X, Liang J, Gu Z, Zhang X, Fan Y.A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate.J Biomed Mater Res Part B-Appl Biomater2009; 89: 177–183.
- 23Lu D, Liang J, Fan Y, Gu Z, Zhang X.In vivo evaluation of a pH-sensitive pullulan-doxorubicin conjugate.Adv Eng Mater2010; 12: B496–B503.
- 24Zhang H, Yamazaki T, Zhi C, Hanagata N.Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides.Nanoscale2012; 4: 6343–6350.
- 25Liang B, He ML, Xiao ZP, Li Y, Chan CY, Kung HF, Shuai XT, Peng Y.Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery.Biochem Biophys Res Commun2008; 367: 874–880.
- 26Kim EM, Jeong HJ, Kim SL, Sohn MH, Nah JW, Bom HS, Park IK, Cho CS.Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.Nuclear Med Biol2006; 33: 529–534.
- 27Lu C, Xing MM, Zhong W.Shell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid-cleavable linkage.Nanomedicine2011; 7: 80–87.
- 28Yim H, Yang SG, Jeon YS, Park IS, Kim M, Lee DH, Bae YH, Na K.The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI.Biomaterials2011; 32: 5187–5194.
- 29Rekha MR, Sharma CP.Blood compatibility and in vitro transfection studies on cationically modified pullulan for liver cell targeted gene delivery.Biomaterials2009; 30: 6655–6664.
- 30Li H, Yang J, Hu X, Liang J, Fan Y, Zhang X.Superabsorbent polysaccharide hydrogels based on pullulan derivate as antibacterial release wound dressing.J Biomed Mater Res Part A2011; 98: 31–39.
- 31Liu R, Li D, He B, Xu X, Sheng M, Lai Y, Wang G, Gu Z.Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles.J Control Release2011; 152: 49–56.
- 32Hansen M, Nielsen S, Berg K.Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.J Immunol Methods1989: 203–210.
- 33Glinel K, Sauvage JP, Oulyadi H, Huguet J.Determination of substituents distribution in carboxymethylpullulans by NMR spectroscopy.Carbohydr Res2000; 328: 343–354.
- 34Wang J, Lu Z, Gao Y, Wientjes MG, Au JL.Improving delivery and efficacy of nanomedicines in solid tumors: Role of tumor priming.Nanomedicine (Lond)2011; 6: 1605–1620.
- 35Wu J, Nantz MH, Zern MA.Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications.Frontiers Biosci2002; 7: d717–d725.
- 36Griffith LG, Lopina S.Microdistribution of substratum-bound ligands affects cell function: Hepatocyte spreading on PEO-tethered galactose.Biomaterials1998; 19( 11–12): 979–986.
- 37Kim SH, Hoshiba T, Akaike T.Effect of carbohydrates attached to polystyrene on hepatocyte morphology on sugar-derivatized polystyrene matrices.J Biomed Mater Res Part A2003; 67: 1351–1359.
- 38Yin C, Ying L, Zhang PC, Zhuo RX, Kang ET, Leong KW, Mao HQ.High density of immobilized galactose ligand enhances hepatocyte attachment and function.J Biomed Mater Res Part A2003; 67: 1093–1104.
- 39Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K.Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery.Molecular BioSystems2005; 1: 242–250.
- 40Luo YL, Shiao YS, Huang YF.Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.ACS Nano2011; 5: 7796–7804.
- 41Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS.Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance.J Control Release2000; 64( 1–3): 143–153.